Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 14, 2025

Allogeneic hematopoietic cell transplantation as the standard of care for blastic plasmacytoid dendritic cell neoplasm in first complete remission.

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMohamed A. Kharfan‐Dabaja

Discussion

Loading...

Member takes

Overview

Observational analysis reveals improved survival with allogeneic hematopoietic cell transplantation in blastic plasmacytoid dendritic cell neoplasm, suggesting potential curative benefits.

Key Points

  • Survival improves significantly when patients with BPDCN undergo allogeneic hematopoietic cell transplantation in first complete remission, with curative potential.
  • Data from multicenter and registry studies support the superior outcomes of allo-HCT, particularly in younger patients fit for myeloablative conditioning.
  • Myeloablative conditioning regimens enhance overall and disease-free survival, but may not be suitable for older or frail patients requiring reduced-intensity approaches.
  • Further research is needed to explore post-transplant strategies and the role of next-generation sequencing in managing blastic plasmacytoid dendritic cell neoplasm.

Cite This Study

Mohamed A. Kharfan‐Dabaja (2025) studied this question.

synapsesocial.com/papers/68c6df7533b72be0b5e43ea8https://doi.org/10.4103/hemoncstem.hemoncstem-d-25-00023
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Blastic plasmacytoid dendritic cell neoplasm (BPDCN) international registry: Assessment of the allo-HCT outcomes2025 · 1 citations
  2. 2Combination of chemotherapy and allogeneic hematopoietic stem cell transplantation for elderly patients with blastic plasmacytoid dendritic cell tumor: a case report and literature review2025
  3. 3Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literature2025
  4. 4Real-World Management of Blastic Plasmacytoid Dendritic Cell Neoplasm at an Academic Center with a Broad Regional Referral Base2025
  5. 5Single center retrospective evaluation of CHOP-based regimens in older patients with treatment naive blastic plasmacytoid dendritic cell neoplasm2025 · 1 citations